Principal Scientist - Global Drug Discovery, Obesity Pharmacology (US)

Novo Nordisk AS

Lexington, MA

JOB DETAILS
LOCATION
Lexington, MA
POSTED
10 days ago

About the Department

Our Research & Development organization brings together the best minds in life science innovation. The teams located in facilities in Lexington, Watertown, Cambridge, and Plainsboro reflect the full R&D continuum-from early research through late-stage clinical development. We are building for the future by creating a distinct R&D community based on collaboration, partnerships, and cutting-edge research across multiple modalities and therapeutic areas. We recognize that improving human health starts here and that patients rely on us. Our R&D hub merges biotech speed and agility with large pharmaceutical company quality, resources, and stability, uniting the best of both worlds to develop new medicines for patients.

The Position

The Principal Scientist will provide scientific leadership in the identification, validation, and advancement of new drug targets related to obesity and obesity-related comorbidities, including cardiovascular disease (CVD) and metabolic dysfunction-associated steatohepatitis (MASH).

The role drives in vivo pharmacology strategies across early and late-stage obesity pipeline programs, enabling translation of novel biology into therapeutic opportunities. As a subject matter expert, the individual will define experimental strategies, guide cross-functional teams, evaluate emerging targets and technologies, and lead external collaborations.

The role also includes mentoring colleagues and representing the organization through high-impact scientific contributions. The Principal Scientist will provide strategic guidance to project teams, evaluate emerging targets and technologies, and propose and oversee external collaborations and strategic partnerships. The Principal Scientist will be responsible for in vivo pharmacology supporting both early and late obesity pipeline programs and mentor junior colleagues in the department. Furthermore, the Principal Scientist will represent the organization to the external scientific community through communication of highly impactful research.

Relationships

Reports to the Director of Obesity Pharmacology (US). Internal relationships include working closely with technical staff and other members of the scientific leadership team, regular collaborations with members of other research departments, and frequent interaction with project managers and colleagues across global R&D. The individual may mentor team members and will interact with external research collaborators from both academia and industry.

Essential Functions

  • Demonstrate proven subject matter expertise and scientific excellence in cardiometabolic biology, including obesity, MASH, and CVD.
  • Demonstrate specialized depth and/or breadth of expertise and actively engage with key areas relevant to pharmaceutical drug development.
  • Identify and drive novel hypotheses toward a next generation of medicines to combat obesity and related comorbidities, with a focus on superior tolerability profiles.
  • Extensive experience working in a matrix organization driving cross-collaborations with different line of businesses and key stakeholders.
  • Plan and design in vivo pharmacology studies in collaboration with technical scientists; advise on experimental execution, interpretation, and communication of results from complex, state-of-the-art in vivo experiments related to obesity, CVD, and MASH.
  • Provide expert-level guidance to project teams on experimental strategies to evaluate emerging targets, biology, and technologies.
  • Collaborate effectively across global sites to set project strategy by leading cross-functional project teams spanning in vitro, omics, translational, and clinical disciplines.
  • Contribute subject matter expertise to develop the research agenda, with clear understanding of the link between scientific goals and overall long-term business needs.
  • Propose new projects that support the strategic agenda and address gaps in technological capabilities and therapeutic areas related to obesity and appetite regulation.
  • Represent the organization through external communication of impactful scientific research via presentations at external conferences, peer-reviewed publications, and patent activity.
  • Maintain deep theoretical knowledge and remain actively connected to the external scientific community through continuous evaluation of relevant literature and emerging technologies.
  • Guide and/or lead global, cross-functional experimental teams to achieve project goals.
  • Provide mentorship and training to colleagues within the field of expertise.
  • Maintain, identify, and initiate key relationships with KOLs and academic partners.
  • Guide other research teams on suitable assays/techniques to interpret and translate in vivo studies to progress the obesity pipeline.

QUALIFICATIONS

  • PhD with 10 years relevant industry or post-doctorate experience is required.
  • Master's degree with 16 years relevant industry or post-doctorate experience can be considered.
  • Bachelor's degree with 22+ years relevant experience can be considered.
  • Extensive hands-on expertise in in vivo models related to Obesity, CVD, and MASH.
  • Experience in women's health is a strong plus.
  • Technical expertise and high attention to detail in planning and designing complex in vivo models.
  • Prior experience using small molecules and/or siRNA in obesity pharmacology drug discovery. Experience with Obesity, MESH and CVD models (telemetry, liver elastography, metabolic cages etc.), along with alternative routes of administration in rodents (e.g., PO, SC, IV, minipump).
  • Proven success leading drug discovery programs and processes in cardiometabolic biology (including, but not limited to, novel target identification, target engagement markers, and collaboration with translational and clinical teams).
  • Experience applying human genetics and omics approaches for target discovery/identification.

Preferred experience includes:

  • Experience working with external CROs and/or academic collaborators.
  • Demonstrated excellent verbal and written communication skills.

Physical Requirements

The job requires occasional travel, including international travel, expected to be less than 10%. There are no additional physical requirements beyond standard office and laboratory activities associated with the role.

The base compensation range for this position is $180,00 to $235,000. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance. Novo Nordisk offers long-term incentive compensation and or company vehicles depending on the positions level or other company factors.

Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex-able vacation policy, and parental leave policy.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk, were not chasing quick fixes - were creating lasting change for long-term health. For over 100 years, weve been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of whats possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, were making healthcare more accessible, treating and defeating diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger - a legacy of impact that reaches far beyond today.

Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.

If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.

About the Company

N

Novo Nordisk AS

Working at Novo Nordisk

 

Life-changing careers

Starting a career at Novo Nordisk is more than getting a job. It is an opportunity to improve the lives of millions of people living with a serious chronic disease.

Whether you are a part of supplying insulin for patients around the world, discovering the next breakthrough at one of our state-of-the-art research centres, working with us is truly life-changing.

 

We are inspired by life

We are a proud life-science company on a mission to ensure that people living with a chronic disease can live a full life. Millions rely on us.

We’re inspired by life in all its forms and shapes, ups and downs, opportunities and challenges. From our colleagues in the lab, working to change lives through pioneering break-through treatments, to our colleagues putting sustainability at the core of our processes and working to prolong the life of our planet, this mission to improve lives is at the core of our every action.

 

Together we drive change

Change is a constant — change in lifestyle, change in technology, change all over. At Novo Nordisk, we don’t wait for change. We drive it.

We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future.

That’s why we continuously push to improve the way we work and the lives of the patients we serve, creating innovative solutions that fit the way people want to live. To accomplish this, we embrace a spirit of open-mindedness and experimentation, striving for excellence without fixating on perfection.

 

Together, we are life-changing

Our company is our people. We know that life is anything but linear and balancing what is important at different stages of our career is never easy. That’s why we make room for diverse life situations, always putting people first. We want to ensure that every employee can achieve a work-life balance that supports their current priorities and where they want to go next.

 

Your development starts here

We value our employees for the unique skills, backgrounds and perspectives they bring to the table. We work continuously to help bring out the best in all of our people, offering opportunities for development and creating an environment of mobility within the company. We strive to offer a workplace that’s great to be in and to be from.

It is very important to us that anyone working with us feels empowered as an employee and as a person. We all should have the opportunity to act fast, make decisions and be agile. 

With a career at our company, you will feel a difference right from the start. A sense of inspiration that comes from a shared belief in driving positive change for people, families and communities everywhere, and it’s a collective effort. We rely on the joint potential and collaboration of our more than 45,000 employees.

In the video above, meet  Marie Darting, one of our scientists, and hear more about her work as a formulation scientist, her perspective on development plans and the impact she feels her work has on people living with a chronic disease.

 

Who we are

We were founded in 1923 and today we are a global healthcare company headquartered just outside Copenhagen, Denmark.

Our purpose is to drive change to defeat diabetes and other serious chronic diseases, such as obesity and rare blood and endocrine disorders. We do so by pioneering  scientific breakthroughs, expanding  access to our medicines , and working to prevent and ultimately cure diabetes.

With almost 100 years of experience, one of the broadest diabetes product portfolios in the healthcare industry, as well as an award-winning pipeline of innovative products, our success is built on our company values – the Novo Nordisk Way.

COMPANY SIZE
2,500 to 4,999 employees
INDUSTRY
Biotechnology/Pharmaceuticals
FOUNDED
1923
WEBSITE
https://www.novonordisk.com/